Genotyping of AR and PSA polymorphisms in a patient with Klinefelter syndrome, non-Hodgkin lymphoma, and adenocarcinoma of the prostate

Santos, Renata Ferreira dos; Rainho, Cláudia Aparecida; Trindade, José Carlos Souza; Filho, José Carlos Souza Trindade; Camargo, João Lauro Viana de; Rogatto, Sílvia Regina

doi:10.1016/j.cancergencyto.2004.01.002

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Introduction1

Prostate Cancer1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2006

2007

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(3 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Synchronous tumors with prostate adenocarcinoma have been reported in the literature [1][2][3][4][5][6][7]. The coincidental discovery of lymphoma during pelvic lymphadenectomy for localized prostate cancer has been estimated to be between 0.2% [2] and 1.2% [6,8].…”

Section: Discussionmentioning

confidence: 96%

See 1 more Smart Citation

Metachronous non-Hodgkin's lymphoma in a patient with localized prostate cancer

et al. 2007

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 96%

“…In the English literature, synchronous lymphoma in patients with prostate cancer has been reported [1][2][3][4][5][6][7]. A detailed search did not reveal metachronous lymphoma in those patients.…”

Section: Introductionmentioning

confidence: 90%

Metachronous non-Hodgkin's lymphoma in a patient with localized prostate cancer

et al. 2007

View full text Add to dashboard Cite

show abstract

“…Allelic imbalance, loss of 8p, mutations in androgen and progesterone receptors, and loss of heterozygosity have been observed in prostate cancer [51][52][53][54][55][56]. Similar to other epithelial cancers, telomerase activity is reduced in this cancer.…”

Section: Prostate Cancermentioning

confidence: 99%

Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations

Verma

Manne

2006

Critical Reviews in Oncology/Hematology

View full text Add to dashboard Cite

Biomarkers present the normal and/or disease state in humans. Genetic and epigenetic biomarkers assessed in easily accessible biological materials are useful in diagnosis, early onset or risk of developing cancer or to predict the treatment efficacy or clinical outcome of different human malignancies. Moreover, some of these markers are expressed during early stages of the tumor development and hence provide an opportunity to develop intervention and treatment strategies. Attempts are being made to validate cancer biomarkers in non-invasively collected samples. Multiplexing of clinically validated markers is still a challenge. Once validated, these markers can be utilized in clinical settings and to identify high risk populations. In this review, the current status of the clinical genetic and epigenetic biomarkers and their implication in cancer diagnosis and risk assessment are discussed.

show abstract

Genotyping of AR and PSA polymorphisms in a patient with Klinefelter syndrome, non-Hodgkin lymphoma, and adenocarcinoma of the prostate

Cited by 2 publications

References 12 publications

Metachronous non-Hodgkin's lymphoma in a patient with localized prostate cancer

Metachronous non-Hodgkin's lymphoma in a patient with localized prostate cancer

Genetic and epigenetic biomarkers in cancer diagnosis and identifying high risk populations

Contact Info

Product

Resources

About